Journal rankings · indicator year 2017
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2017
Oncology journal rankings 2017
213 ranked journals · Subfield in Medicine
Oncology has 213 ranked journals in 2017. The median journal has an OJR of 0.84, below the world average of 1.00, up 0.01 on 2016; Q1 starts at OJR 1.49. The top three are CA A Cancer Journal for Clinicians, Nature Medicine, and The Lancet Oncology.
Ranks and citation indicators: 2017. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2014–2016, the window the 2017 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery852
- Pulmonary and Respiratory Medicine324
- Public Health, Environmental and Occupational Health270
- Cardiology and Cardiovascular Medicine266
- Oncology213
- Infectious Diseases198
- Epidemiology185
- Neurology157
- Endocrinology, Diabetes and Metabolism156
- Radiology, Nuclear Medicine and Imaging144
- Physiology143
- Psychiatry and Mental health142
Show all 42 subfields
- Orthopedics and Sports Medicine107
- Pediatrics, Perinatology and Child Health97
- Ophthalmology87
- Dermatology83
- Hematology74
- Obstetrics and Gynecology68
- Rheumatology65
- Nephrology58
- Reproductive Medicine50
- Complementary and alternative medicine47
- Pharmacology46
- Emergency Medicine38
- Geriatrics and Gerontology35
- Otorhinolaryngology32
- Rehabilitation29
- Pathology and Forensic Medicine25
- Critical Care and Intensive Care Medicine23
- Hepatology23
- Genetics21
- Immunology and Allergy20
- Urology13
- Anesthesiology and Pain Medicine12
- Gastroenterology7
- Internal Medicine4
- Family Practice3
- Transplantation3
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
213 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2016. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2014–2016, the window the 2017 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2014–2016 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2008 to 2017. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 82.50Q1 | 261.76 75.78 up from 2016 | 79 | 100% | $4,330 | ||
2Nature MedicineNature Portfolio · United States | 7.70Q1 | 22.65 5.17 up from 2016 | 912 | 55% | $12,690 | ||
3The Lancet OncologyElsevier BV · United Kingdom | 7.43Q1 | 18.19 0.12 up from 2016 | 1,158 | 31% | $7,280 | ||
4Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 6.42Q1 | 16.33 1.65 up from 2016 | 2,083 | 5% | — | ||
5Cancer CellCell Press · Netherlands | 6.26Q1 | 16.12 3.52 down from 2016 | 578 | 100% | $10,400 | ||
6Breast CareKarger Publishers · Switzerland | 5.42Q1 | 23.27 21.73 up from 2016 | 213 | 91% | — | ||
7Annals of OncologyElsevier BV · Netherlands | 3.79Q1 | 10.37 0.18 up from 2016 | 1,376 | 100% | $5,080 | ||
8JAMA OncologyAmerican Medical Association · United States | 3.73Q1 | 8.35 0.21 up from 2016 | 778 | 52% | — | ||
9Cancer Immunology ResearchAmerican Association for Cancer Research · United States | 3.41Q1 | 9.86 0.96 up from 2016 | 382 | 30% | — | ||
10Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.35Q1 | 9.09 0.07 down from 2016 | 2,193 | 40% | — | ||
11Seminars in Cancer BiologyElsevier BV · United States | 3.20Q1 | 9.94 0.14 up from 2016 | 184 | 46% | $6,060 | ||
12JNCI Journal of the National Cancer InstituteOxford University Press · United States | 2.96Q1 | 8.37 0.33 down from 2016 | 808 | 87% | $5,436 | ||
13European Journal of EpidemiologySpringer Science+Business Media · Italy | 2.90Q1 | 6.81 0.11 up from 2016 | 323 | 60% | $3,690 | ||
14Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 2.73Q1 | 7.41 2.29 up from 2016 | 418 | 97% | — | ||
15International Journal of CancerWiley · United States | 2.65Q1 | 4.88 2.62 down from 2016 | 1,671 | 84% | $5,030 | ||
16Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.56Q1 | 9.41 0.40 up from 2016 | 304 | 33% | $4,910 | ||
17CancerWiley · United States | 2.55Q1 | 5.47 0.31 down from 2016 | 1,652 | 87% | $4,790 | ||
18Therapeutic Advances in Medical OncologyOASAGE Publishing · United Kingdom | 2.38Q1 | 6.49 1.10 down from 2016 | 102 | 100% | $2,800 | ||
19Breast Cancer ResearchOABioMed Central · United Kingdom | 2.37Q1 | 7.06 0.10 up from 2016 | 490 | 100% | $4,190 | ||
20Journal of Hematology & OncologyOABioMed Central · United Kingdom | 2.37Q1 | 8.08 1.25 up from 2016 | 355 | 100% | $4,990 | ||
21CancersOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.36Q1 | 6.20 0.08 up from 2016 | 357 | 100% | $3,499 | ||
22British Journal of CancerSpringer Nature · United Kingdom | 2.35Q1 | 6.62 0.22 down from 2016 | 1,474 | 100% | $5,190 | ||
23Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.33Q1 | 6.86 1.30 up from 2016 | 1,053 | 21% | — | ||
24The OncologistOAAlphaMed Press · United Kingdom | 2.14Q1 | 5.56 0.70 up from 2016 | 601 | 99% | $3,852 | ||
25Clinical Pharmacology & TherapeuticsWiley · United States | 2.12Q1 | 5.11 0.11 down from 2016 | 611 | 42% | $4,410 | ||
26Frontiers in OncologyOAFrontiers Media · Switzerland | 2.09Q1 | 5.32 0.54 down from 2016 | 925 | 100% | $3,801 | ||
27Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 2.01Q1 | 5.35 0.46 down from 2016 | 858 | 46% | — | ||
28Journal for ImmunoTherapy of CancerOABMJ · United Kingdom | 1.94Q1 | 6.88 2.78 up from 2016 | 277 | 100% | $2,490 | ||
29Seminars in OncologyElsevier BV · United States | 1.94Q1 | 5.35 1.46 down from 2016 | 267 | 22% | $3,550 | ||
30Clinical and Translational GastroenterologyOALippincott Williams & Wilkins · United States | 1.92Q1 | 4.65 0.47 up from 2016 | 157 | 100% | $2,800 | ||
31Cancer Management and ResearchOADove Medical Press · New Zealand | 1.92Q1 | 4.11 0.62 down from 2016 | 90 | 100% | $2,836 | ||
32Journal of Cancer EpidemiologyHindawi Publishing Corporation · United Kingdom | 1.91Q1 | 2.08 3.15 down from 2016 | 38 | 100% | $950 | ||
33Cancer Prevention ResearchAmerican Association for Cancer Research · United States | 1.88Q1 | 4.42 0.07 down from 2016 | 377 | 69% | — | ||
34Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.85Q1 | 4.65 1.00 up from 2016 | 169 | 12% | $4,890 | ||
35JNCI MonographsOxford University Press · United Kingdom | 1.76Q1 | 2.00 3.00 down from 2016 | 60 | 88% | — | ||
36The Cancer JournalLippincott Williams & Wilkins · United States | 1.74Q1 | 3.78 1.21 down from 2016 | 206 | 28% | — | ||
37Cancer Biology and MedicineOAChinese Anti-Cancer Association · China | 1.72Q1 | 4.27no 2016 value | 44 | 100% | $1,500 | ||
38ESMO OpenOAElsevier BV · Netherlands | 1.69Q1 | 3.69no 2016 value | 88 | 100% | $3,910 | — | |
39Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.69Q1 | 4.94 0.28 up from 2016 | 832 | 27% | — | ||
40npj Breast CancerOANature Portfolio · United States | 1.66Q1 | 5.13 3.63 up from 2016 | 40 | 100% | $3,790 | ||
41Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.65Q1 | 5.59 0.46 up from 2016 | 461 | 31% | $4,190 | ||
42Clinical Medicine Insights OncologyOASAGE Publishing · United Kingdom | 1.64Q1 | 3.98 1.07 up from 2016 | 66 | 100% | $2,650 | ||
43ImmunoTargets and TherapyOADove Medical Press · New Zealand | 1.64Q1 | 5.96 4.92 up from 2016 | 36 | 100% | $2,320 | ||
44Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.63Q1 | 4.12 0.31 down from 2016 | 215 | 11% | $3,950 | ||
45Nature Reviews Clinical OncologyNature Portfolio · United Kingdom | 1.61Q1 | 7.17 1.28 up from 2016 | 655 | 17% | — | ||
46Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.60Q1 | 4.51 0.52 down from 2016 | 413 | 100% | $4,590 | ||
47World Journal of Clinical OncologyOABaishideng Publishing Group · United States | 1.60Q1 | 3.03 1.06 down from 2016 | 197 | 100% | — | ||
48Current Oncology ReportsSpringer Science+Business Media · United States | 1.60Q1 | 3.95 0.48 up from 2016 | 194 | 20% | $5,090 | ||
49The Journal of Pathology Clinical ResearchOAWiley · United Kingdom | 1.59Q1 | 4.65 3.21 up from 2016 | 54 | 100% | $3,250 | ||
49Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.59Q1 | 3.97 0.87 up from 2016 | 647 | 100% | — |
Subfields of Medicine, with Oncology highlighted.
- Surgery852
- Pulmonary and Respiratory Medicine324
- Public Health, Environmental and Occupational Health270
- Cardiology and Cardiovascular Medicine266
- Oncology213
- Infectious Diseases198
- Epidemiology185
- Neurology157
- Endocrinology, Diabetes and Metabolism156
- Radiology, Nuclear Medicine and Imaging144
- Physiology143
- Psychiatry and Mental health142
- Orthopedics and Sports Medicine107
- Pediatrics, Perinatology and Child Health97
- Ophthalmology87
- Dermatology83
- Hematology74
- Obstetrics and Gynecology68
- Rheumatology65
- Nephrology58
- Reproductive Medicine50
- Complementary and alternative medicine47
- Pharmacology46
- Emergency Medicine38
- Geriatrics and Gerontology35
- Otorhinolaryngology32
- Rehabilitation29
- Pathology and Forensic Medicine25
- Critical Care and Intensive Care Medicine23
- Hepatology23
- Genetics21
- Immunology and Allergy20
- Urology13
- Anesthesiology and Pain Medicine12
- Gastroenterology7
- Internal Medicine4
- Family Practice3
- Transplantation3
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2017. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
81 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2014–2016, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2017. Publication window: 2014–2016. How these summaries are calculated
- Ranked journals
- 213
- Window papers (baseline)
- 105,891 +12.8% from indicator year 2014
- Median OJR
- 0.84 -13.3% from indicator year 2014
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2014–2016 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.